Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Kuros Biosciences treats first patient in clinical trial of MagnetOs Putty for posterolateral spine fusion
Kuros Biosciences announces treatment of first patient in Australia with MagnetOs for spine fusion
Kuros to receive $2 million milestone payment from Checkmate Pharmaceuticals
Kuros Biosciences publishes invitation to the Annual General Meeting 2021
English version
Kuros Biosciences reports results for the full year 2020